KATE AI
Overview
Mednition’s KATE AI is a nurse-built clinical decision support tool for emergency departments that analyzes incoming patients in real-time to flag high-risk cases that standard acuity scoring might miss. It is designed to empower emergency nurses, reduce clinical risk, and improve the quality of care. KATE AI seamlessly integrates into existing workflows and Electronic Health Record (EHR) systems, requiring zero changes for nurses. The platform provides real-time AI-powered clinical guidance and nursing education to support ED Triage accuracy and early sepsis detection, ultimately improving clinical outcomes, health equity, nursing staff retention, and operational and financial outcomes.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Real-time AI-powered Clinical Decision Support
- Seamless EHR Integration (Zero Workflow Change)
- Early Sepsis Detection (KATE Sepsis Module)
- Acuity & Risk Identification (KATE Triage Module)
- Clinical Natural Language Processing (C-NLP)
- Clinical Data Engine (CDE) for Real-time Analytics
- Support for Emergency Severity Index (ESI) Triage
- Health Equity Gap Reduction
- Real-time dashboards for measuring clinical performance at ED Triage
- Aggregation analysis of patient chief complaint vs. disposition and diagnosis
Use Cases
- Improving Emergency Department (ED) Triage Accuracy and reducing unwarranted clinical variation
- Early Identification and prioritization of High-Risk Patients (e.g., Sepsis, Stroke, Maternal Risk)
- Boosting ED Throughput, patient flow, and reducing Length of Stay (LOS)
- Reducing clinical risk and promoting health equity by mitigating gender or other biases in triage decisions
- Empowering nurses with real-time clinical guidance and education
- Improving operational efficiency and financial performance in emergency departments
Details
| Category | Clinical Decision Support & Reference, Triage & ER/ICU AI |
| Pricing |
Fee-based, not publicly disclosed.
|
| Deployment | Cloud, SaaS |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Unknown AI-estimated KATE Sepsis has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA), recognizing it as a significant advancement in the early detection of sepsis. This designation was granted because KATE Sepsis demonstrated the ability to improve early detection of sepsis at Emergency Department (ED) Triage over standard screening protocols by up to 118%. |
| Integrations | |
| EHR | Not specified |
| Specialties | Critical Care, Emergency Medicine, Hospital Medicine |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate KATE AI
No FAQs available yet for this tool.